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Ribosomal peptide natural products (RiPPs) offer a new frontier for discovering and engineering bioactive
small molecules. In this issue of Chemistry & Biology, Young and colleagues overcome hurdles that have
slowed the development of RiPPs, leading to in vivo synthesis of new thiopeptide antibiotics.Ribosomally synthesized peptides are
often posttranslationally modified to pro-
duce complex natural products known
as ribosomal peptide natural products
(RiPPs), which are ubiquitous in all forms
of life (Arnison et al., 2012). In recent
years, the rate of discovery of these
compounds and their biosynthetic path-
ways has increased greatly. Many dif-
ferent types of bioactive peptides, and
even small molecule alkaloids, are now
known to be RiPPs. A diverse array
of novel posttranslational modifications
continues to be uncovered (Freeman
et al., 2012). RiPP biological activities
and natural roles are likewise highly
diverse, as they have been documented
to act as ion channel blockers, enzyme
cofactors, antibiotics, quorum sensing
molecules, potential anticancer agents,
and many others.
Although there are many types of RiPP
pathways, there are a few features that
they share. Most important among these,
RiPPs are synthesized first as precursor
peptides, which are then modified by
enzymes (Arnison et al., 2012). Precursor
peptides usually contain a few key
elements, including the leader peptideFigure 1. Generic Route to RiPPs
A precursor peptide is modified by enzymes to form the natural product RiPP.
In the process, the leader peptide is often removed.and the core peptide. The
leader peptide can be impor-
tant for several reasons, but
most crucially, it often recruits
modifying enzymes. The core
peptide directly encodes the
final natural products. Most
RiPPs undergo a process of
proteolysis, where the leader
sequence is removed, leaving
the mature natural product
that results from the core
peptide sequence (Figure 1).
The partitioning of func-
tions in the precursor peptidemakes RiPPs promising platforms for
in vivo engineering. In bacteria, early
work with lantibiotic pathways revealed
that many point mutations in the
core peptide could be accommodated
by posttranslational machinery (Kuipers
et al., 1996). Subsequently, studies of
native peptide variation revealed that, in
extreme cases, bacterial RiPP pathways
naturally exhibit hypervariable core pep-
tide sequences, while the enzymes and
leader peptides remain constant (Donia
et al., 2006; Li et al., 2010). Large libraries
have been generated by mutagenesis of
the core peptide sequences (Pan and
Link, 2011). These and other studies
show that bacterial RiPP biosynthetic
machinery often tolerates highly diverse
core peptide sequences.
Mutation of native sequences is often
driven by the desire to create variants
with improved pharmacological proper-
ties (Pan and Link, 2011). The diversity of
RiPPs has also led to the capability
of generating wholly unnatural ‘‘natural
products’’ or libraries thereof that could
be used to screen against unanticipated,
new targets (Donia et al., 2006; Knappe
et al., 2011). In order to fully harness theChemistry & Biology 19, December 21, 2012 ªcapability of these libraries, it is neces-
sary to understand sequence constraints
imposed by the biosynthetic pathway
and by the producing microbe.
There are two hurdles that have slowed
the development of in vivo RiPP libraries.
First, methods are lacking to produce
appropriate libraries of genetic mutants.
Second, it is difficult to determine which
compounds are produced in vivo, since
normally chemical extraction and analysis
is required. Although it is straightforward
to isolate individual natural products and
analyze them, the isolation steps greatly
add to the time that it takes to process
a library. For example, direct measure-
ment of a 96-well plate by MALDI takes
a few minutes, while an extraction and
purification protocol might take hours or
even days per plate. In addition, if an
unexpected compound is produced, it
may not be readily extracted and ob-
served by previous methods. Together,
these problems make the generation and
analysis of libraries expensive and time
consuming.
In this issue of Chemistry & Biology,
Young et al. (2012) overcome these two
hurdles using the thiostrepoton-like thio-2012 Elsevipeptide GE37468 as a model
(Figure 2). Thiopeptides are
potent antibiotics that are
used extensively in biotech-
nology and that have even
advanced to clinical trials.
There is significant interest in
generating improved ana-
logs. Moreover, thiopeptides
follow an intricate biosyn-
thetic pathway employing a
cascade of chemically inter-
esting, biosynthetically novel
posttranslational modifica-
tions (Arndt et al., 2009).er Ltd All rights reserved 1501
Figure 2. Facile Mutagenesis of the Thiopeptide GE37468
In 1 out of 133 variants, threonine 2 (T; blue) wasmutated to cysteine. Themodification changed the native
oxazole to a thiazole derivative with more potent antibiotic activity.
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PreviewsYoung et al. (2012) present a strategy
for the practical expression of peptide
variants in Streptomyces. The authors
describe several steps to greatly improve
the recombinant yield to a practical level.
In addition, they streamline the process
of creating libraries. Many of the methods
are well validated in other types of
systems. However, their application to
RiPPs is creative and takes away what is
otherwise a limiting step. Taken together,
the methods provide a practical platform
to explore chemical space in an efficient
way. Several of the methods are likely
widely applicable to RiPPs.
The authors also present a method to
solve the detection problem. A MALDI-
based mass spectrometry method is
employed, which directly measures the
recombinant peptides within bacterial
clones in a microtiter plate without pro-1502 Chemistry & Biology 19, December 21,cessing. Thus, all that is required is to
transform a mutant library into the target
strain and then simply grow it in small
scale prior to analysis. In principle, the
complete substrate specificity of the
biosynthetic pathway might then be
determined in an automated fashion.
Finally, an antibiotic assay was simulta-
neously employed, allowing simple dis-
covery of active variants.
The methods are employed here to
better understand the GE37468 pathway
and to create improved variants. Seven
individual positions are varied, leading
to possibly 133 sequence variations.
Twenty-nine of these were processed by
the enzymatic machinery to afford 153
thiopeptide variants, and more active
versions of GE37468 were identified.
This approach allowed the authors to
understand pathway selectivity at the2012 ª2012 Elsevier Ltd All rights reservedseven positions and provided novel
insights into the biosynthetic pathway.
As one example, the position natively
containing tyrosine was most tolerant of
substitution, accepting eight different
amino acids. However, changes at this
position led to a block of posttranslational
modification at a neighboring isoleucine
residue. In addition, the resulting struc-
ture-activity relationship profile provided
unique information and novel active mole-
cules that would be difficult to generate
using other foreseeable methods. This
approach thus allowed the authors to
efficiently decode the substrate limita-
tions of the pathway while simultaneously
recoding it to generate new, bioactive
small molecules.
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